Cargando…
Current Evidence for IL-17/23 Blockade for the Treatment of Lupus Nephritis
In the current medical literature, there is increasing evidence for the involvement of the interleukin (IL)-17/23 axis and the potential role of Th17 cells in the pathogenesis of lupus nephritis. Knowledge about the interaction of these immunological pathways in the development of autoimmune disease...
Autores principales: | Santacruz, Juan Camilo, Pulido, Sandra, Arzuaga, Angelo, Mantilla, Marta Juliana, Santos, Ana María, Londono, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720001/ https://www.ncbi.nlm.nih.gov/pubmed/34993035 http://dx.doi.org/10.7759/cureus.20087 |
Ejemplares similares
-
Lupus Cystitis, From Myth to Reality: A Narrative Review
por: Santacruz, Juan Camilo, et al.
Publicado: (2021) -
A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus
por: Santacruz, Juan Camilo, et al.
Publicado: (2022) -
Perimyocarditis With Acute Heart Failure as the First Manifestation of Systemic Lupus Erythematosus
por: Santacruz, Juan Camilo, et al.
Publicado: (2022) -
A Practical Overview of the Articular Manifestations of Systemic Lupus Erythematosus
por: Santacruz, Juan Camilo, et al.
Publicado: (2023) -
HIV and COVID-19 Coinfection: A Synergism That Results in More Severe Forms of Reactive Arthritis
por: Santacruz, Juan Camilo, et al.
Publicado: (2021)